RU2004100875A - MEANS FOR PREVENTION OF VIRAL HEPATITIS C - Google Patents

MEANS FOR PREVENTION OF VIRAL HEPATITIS C Download PDF

Info

Publication number
RU2004100875A
RU2004100875A RU2004100875/15A RU2004100875A RU2004100875A RU 2004100875 A RU2004100875 A RU 2004100875A RU 2004100875/15 A RU2004100875/15 A RU 2004100875/15A RU 2004100875 A RU2004100875 A RU 2004100875A RU 2004100875 A RU2004100875 A RU 2004100875A
Authority
RU
Russia
Prior art keywords
prevention
viral hepatitis
bark extract
birch bark
hepatitis
Prior art date
Application number
RU2004100875/15A
Other languages
Russian (ru)
Other versions
RU2264820C2 (en
Inventor
бин Петр Григорьевич Дер (RU)
Петр Григорьевич Дерябин
Дмитрий Константинович Львов (RU)
Дмитрий Константинович Львов
Владимир Владимирович Балакшин (RU)
Владимир Владимирович Балакшин
ков Алексей Николаевич Чист (RU)
Алексей Николаевич Чистяков
Original Assignee
Ооо "Березовый Мир" (Ru)
Ооо "Березовый Мир"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ооо "Березовый Мир" (Ru), Ооо "Березовый Мир" filed Critical Ооо "Березовый Мир" (Ru)
Priority to RU2004100875/15A priority Critical patent/RU2264820C2/en
Priority to PCT/RU2004/000042 priority patent/WO2005021007A1/en
Publication of RU2004100875A publication Critical patent/RU2004100875A/en
Application granted granted Critical
Publication of RU2264820C2 publication Critical patent/RU2264820C2/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Claims (3)

1. Применение экстракта бересты для профилактики вирусного гепатита С.1. The use of birch bark extract for the prevention of viral hepatitis C. 2. Препарат для профилактики вирусного гепатита С, включающий в себя экстракт бересты и фармацевтически приемлемый носитель.2. A drug for the prevention of viral hepatitis C, which includes birch bark extract and a pharmaceutically acceptable carrier. 3. Способ профилактики вирусного гепатита С, заключающийся во введении пациенту препарата, содержащего экстракт бересты и фармацевтически приемлемый носитель.3. A method for the prevention of hepatitis C virus, which consists in administering to the patient a preparation containing birch bark extract and a pharmaceutically acceptable carrier.
RU2004100875/15A 2003-08-28 2004-01-15 Preparation for preventing viral hepatitis c RU2264820C2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
RU2004100875/15A RU2264820C2 (en) 2004-01-15 2004-01-15 Preparation for preventing viral hepatitis c
PCT/RU2004/000042 WO2005021007A1 (en) 2003-08-28 2004-02-09 Prevention and treatment of viral hepatitis c

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2004100875/15A RU2264820C2 (en) 2004-01-15 2004-01-15 Preparation for preventing viral hepatitis c

Publications (2)

Publication Number Publication Date
RU2004100875A true RU2004100875A (en) 2005-06-20
RU2264820C2 RU2264820C2 (en) 2005-11-27

Family

ID=35835431

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004100875/15A RU2264820C2 (en) 2003-08-28 2004-01-15 Preparation for preventing viral hepatitis c

Country Status (1)

Country Link
RU (1) RU2264820C2 (en)

Also Published As

Publication number Publication date
RU2264820C2 (en) 2005-11-27

Similar Documents

Publication Publication Date Title
WO2007038507A3 (en) Modified 4'-nucleosides as antiviral agents
EA200200812A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING LOW DOSE OF ENTEKAVIR, AND ITS APPLICATION
WO2003051306A3 (en) N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
WO2004000209A3 (en) Administration of therapeutic viruses
EP1889843A4 (en) Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds
EA200601467A1 (en) MACROCYCLIC COMPOUNDS AS VIRAL REPLICATION INHIBITORS
RU2007132971A (en) METHODS AND MATERIALS WITH TRANS-CLOMIPHENES FOR TREATMENT OF MEN'S INFERTILITY
ATE499939T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLIBANSERIN POLYMORPHO A
EP1765330A4 (en) Pyranoindole derivatives and the use thereof for the treatment of hepatitis c virus infection or disease
WO2006045616A3 (en) β-L-N4-HYDROXYCYTOSINE DEOXYNUCLEOSIDES AND THEIR USE AS PHARMACEUTICAL AGENTS IN THE PROPHYLAXIS OR THERAPY OF VIRAL DISEASES
GEP20084377B (en) Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections
ATE276761T1 (en) PREVENTION OF TYPE 1 DIABETES AND OTHER NON-POLIO ENTEROVIRUSES
RU2004100875A (en) MEANS FOR PREVENTION OF VIRAL HEPATITIS C
MD3121F1 (en) Method of viral hepatitis B prophylaxis
RU2003126207A (en) MEANS FOR TREATING VIRAL HEPATITIS C
WO2002007760A3 (en) Therapeutic agent against aids comprising anti hiv goat antibody
RU2005117538A (en) STRAIN ASIA-1 / TAJIKISTAN / 2004 (1960) Virus of foot and mouth disease, TYPE ASIA-1, FOR THE MANUFACTURE OF DIAGNOSTIC AND / OR VACCINE PREPARATIONS
JP5592935B2 (en) Kumabori polymer extract and its preparation and use
WO2002030458A8 (en) Yersinia adhesion protein as vaccine adjuvant
DE60321227D1 (en) CYTOTOXIC PHARMACEUTICAL COMPOSITION
HRP20151389T1 (en) An antiviral 1-phenyl-2,5-dibenzimidazol-5-yl-pyrrolidine derivative
RU2004123241A (en) DRUG ONCOLOGICAL DISEASES
RU2004130509A (en) MEANS FOR CORRECTION OF TOXIC HEPATORENAL SYNDROME INDUCED BY FOUR CHLORIDE CARBON AND METHOD FOR CORRECTION OF TOXIC HEPATORENAL SYNDROME INDUCED BY FOUR CHLOROGEN CHLORIDE
Morris Liquorice offers potential treatment for SARS
RU2001127052A (en) The strain of the Ebola virus "Zaire Ch-15" for conducting model experiments and the preparation of diagnostic and vaccine preparations